Allovir Stock Net Income
| ALVRDelisted Stock | USD 9.81 0.15 1.55% |
Allovir fundamentals help investors to digest information that contributes to Allovir's financial success or failures. It also enables traders to predict the movement of Allovir Stock. The fundamental analysis module provides a way to measure Allovir's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Allovir stock.
Allovir |
Allovir Company Net Income Analysis
Allovir's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Allovir Net Income | (58.77 M) |
Most of Allovir's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Allovir is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Allovir reported net income of (58.77 Million). This is 117.22% lower than that of the Biotechnology sector and 183.9% lower than that of the Health Care industry. The net income for all United States stocks is 110.29% higher than that of the company.
Allovir Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Allovir's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Allovir could also be used in its relative valuation, which is a method of valuing Allovir by comparing valuation metrics of similar companies.Allovir is currently under evaluation in net income category among its peers.
Allovir Fundamentals
| Return On Equity | -0.8 | ||||
| Return On Asset | -0.37 | ||||
| Current Valuation | (69.57 M) | ||||
| Shares Outstanding | 115.36 M | ||||
| Shares Owned By Insiders | 49.11 % | ||||
| Shares Owned By Institutions | 42.94 % | ||||
| Number Of Shares Shorted | 64.61 K | ||||
| Price To Book | 0.43 X | ||||
| Gross Profit | 165 K | ||||
| EBITDA | (65.44 M) | ||||
| Net Income | (58.77 M) | ||||
| Cash And Equivalents | 172.67 M | ||||
| Cash Per Share | 1.91 X | ||||
| Total Debt | 5.24 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 8.18 X | ||||
| Book Value Per Share | 1.05 X | ||||
| Cash Flow From Operations | (67.7 M) | ||||
| Short Ratio | 26.44 X | ||||
| Earnings Per Share | (0.90) X | ||||
| Price To Earnings To Growth | (0.06) X | ||||
| Target Price | 1.2 | ||||
| Beta | 0.74 | ||||
| Market Capitalization | 85.25 M | ||||
| Total Asset | 118.55 M | ||||
| Retained Earnings | (714.96 M) | ||||
| Working Capital | 113.31 M | ||||
| Current Asset | 61.62 M | ||||
| Current Liabilities | 53.23 M | ||||
| Net Asset | 118.55 M |
About Allovir Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Allovir's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allovir using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allovir based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Allovir
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allovir position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will appreciate offsetting losses from the drop in the long position's value.Moving against Allovir Stock
The ability to find closely correlated positions to Allovir could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allovir when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allovir - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allovir to buy it.
The correlation of Allovir is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allovir moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allovir moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allovir can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allovir. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Allovir Stock
If you are still planning to invest in Allovir check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allovir's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |